These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2443448)

  • 21. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection.
    Watschinger B; Pascual M
    J Am Soc Nephrol; 2002 Sep; 13(9):2420-3. PubMed ID: 12191988
    [No Abstract]   [Full Text] [Related]  

  • 22. Insights from the immunopathology of transplantation.
    Platt JL
    Springer Semin Immunopathol; 2003 Sep; 25(2):91-4. PubMed ID: 12955461
    [No Abstract]   [Full Text] [Related]  

  • 23. C4 polymorphism: use of a monoclonal antibody to distinguish C4A and C4B locus products.
    O'Neill GJ
    Vox Sang; 1984; 47(5):362-5. PubMed ID: 6334403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of both isotypes of complement C4, C4A and C4B, in normal human glomeruli.
    Feucht HE; Jung CM; Gokel MJ; Riethmüller G; Zwirner J; Brase A; Held E; O'Neill GJ
    Kidney Int; 1986 Dec; 30(6):932-6. PubMed ID: 3546915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Report of studies on monoclonal antibodies (MABS) to complement components.
    Voak D; Nilsson U
    J Immunogenet; 1990; 17(4-5):337-42. PubMed ID: 2093729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4.
    Chakravarti DN; Campbell RD; Gagnon J
    FEBS Lett; 1983 Apr; 154(2):387-90. PubMed ID: 6832377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 'Partial inhibition' of anti-Rg and anti-Ch reagents. II. Demonstration of separable antibodies for different determinants.
    Giles CM
    Vox Sang; 1985; 48(3):167-73. PubMed ID: 2580392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C4d complement split product expression in chronic rejection of renal allograft.
    Mróz A; Durlik M; Cieciura T; Pazik J; Baczkowska T; Chmura A; Nazarewski S; Lao M
    Transplant Proc; 2003 Sep; 35(6):2190-2. PubMed ID: 14529884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal anti-human C4b antibodies: stabilization and inhibition of the classical-pathway C3 convertase.
    Ichihara C; Nakamura T; Nagasawa S; Koyama J
    Mol Immunol; 1986 Feb; 23(2):151-7. PubMed ID: 2422544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A molecular basis for the two locus model of human complement component C4.
    Roos MH; Mollenhauer E; Démant P; Rittner C
    Nature; 1982 Aug; 298(5877):854-6. PubMed ID: 6180321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.
    Briggs DC; Senaldi G; Isenberg DA; Welsh KI; Vergani D
    Ann Rheum Dis; 1991 Apr; 50(4):251-4. PubMed ID: 2029208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma.
    Nitsche JF; Tucker ES; Sugimoto S; Vaughan JH; Curd JG
    Am J Clin Pathol; 1981 Nov; 76(5):679-84. PubMed ID: 6794354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An international reference typing for Ch and Rg determinants on rare human C4 allotypes.
    Rittner C; Tippett P; Giles CM; Mollenhauer E; Berger R; Nordhagen R; Buskjaer L; Bruun-Petersen G; Lamm L; Roos MH
    Vox Sang; 1984; 46(4):224-34. PubMed ID: 6201005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The antigenic determinants, Rg/Ch/WH, expressed by Japanese C4 allotypes.
    Giles CM; Tokunaga K; Zhang WJ; Tanaka H; Endoh N; Juji T
    J Immunogenet; 1988; 15(5-6):267-75. PubMed ID: 2475543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Classical pathway of complement activation in normal and diseased human glomeruli.
    Zwirner J; Felber E; Herzog V; Riethmüller G; Feucht HE
    Kidney Int; 1989 Dec; 36(6):1069-77. PubMed ID: 2689750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The murine H-2.7 specificity is an antigenic determinant of C4d, a fragment of the fourth component of the complement system.
    Ferreira A; David CS; Nussenzweig V
    J Exp Med; 1980 Jun; 151(6):1424-35. PubMed ID: 6155423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles.
    Yu CY; Campbell RD
    Immunogenetics; 1987; 25(6):383-90. PubMed ID: 2439447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A monoclonal antibody which can distinguish between the two isotypes of human C4.
    Hsiung LM; Mason DW; Dodds AW
    Mol Immunol; 1987 Jan; 24(1):91-6. PubMed ID: 3614207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The chemical structure of the C4d fragment of the human complement component C4.
    Chakravarti DN; Campbell RD; Porter RR
    Mol Immunol; 1987 Nov; 24(11):1187-97. PubMed ID: 3696167
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Partial inhibition' of anti-Rg and anti-Ch reagents. I. Assessment for Rg/Ch typing by inhibition.
    Giles CM
    Vox Sang; 1985; 48(3):160-6. PubMed ID: 3984302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.